Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
NCT06605417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-02-27
Summary
The primary objective of this study is to identify the molecular identity profiles of all cellular states that characterize the progression from benign nevi to malignant melanoma in CAYA patients with L/GCMN. The secondary objectives are:
* To longitudinally characterize the cell-free DNA (cfDNA) from CAYA patients.
* To improve the early diagnosis and treatments for intermediate conditions such as L/GCMN through evidence-based interpretation of personal risk from endogenous or exogenous sources.
* To test pre-clinical strategies to best model and improve patient response.
Conditions
- Congenital Melanocytic Nevi
- Melanoma, Skin
- Nevi and Melanomas
Interventions
- GENETIC
-
Methylomics
Methylomics analysis of FFPE blocks and frozen tissues
- GENETIC
-
RNA sequencing
RNA sequencing of FFPE blocks and frozen tissues
- GENETIC
-
Spatial transcriptomics
Spatial transcriptomics of FFPE blocks and frozen tissues
- GENETIC
-
Liquid biopsy
cfDNA characterization extracted from blood/saliva
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator UNKNOWN -
University Hospital Tuebingen
collaborator OTHER -
University of Florence
collaborator OTHER -
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
collaborator OTHER -
University Of Perugia
collaborator OTHER -
German Cancer Research Center
collaborator OTHER - collaborator OTHER
-
Maria Sklodowska-Curie National Research Institute of Oncology
collaborator OTHER -
Institut Curie
collaborator OTHER -
Medical University of Gdansk
collaborator OTHER -
Princess Maxima Center for Pediatric Oncology
collaborator OTHER -
Institut Català d'Oncologia
collaborator OTHER -
Fundacion Clinic per a la Recerca Biomédica
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2026-03-31
- Completion
- 2026-11-30
Countries
- France
- Spain
Study Locations
More Related Trials
-
Validation of a Molecular Prognostic Test for Eye Melanoma
NCT00406120 ·Status: WITHDRAWN
-
Natural History Study of Moles and Suspicious Melanoma
NCT00288938 ·Status: COMPLETED
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
NCT07277920 ·Status: RECRUITING
-
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
NCT05889481 ·Status: UNKNOWN
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
NCT00952939 ·Status: COMPLETED
-
Finistere Myeloma Observatory (OMYFIN)
NCT06552221 ·Status: COMPLETED
-
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
NCT05179174 ·Status: UNKNOWN
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
A Prospective Natural History Study in Uveal Melanoma
NCT04588662 ·Status: ACTIVE_NOT_RECRUITING
-
Differential Risks for Melanoma: p16 and DNA Repair
NCT00615095 ·Status: COMPLETED
-
The Registry Study of Genetic Alterations of Melanoma in Taiwan
NCT06952400 ·Status: RECRUITING
-
Cytogenetic Study of Ocular Melanoma
NCT00344799 ·Status: COMPLETED
-
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
NCT01444560 ·Status: COMPLETED
-
Analysis of Molecular Biomarkers in Periocular Adnexal Tumours
NCT06080009 ·Status: RECRUITING ·Phase: NA
-
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
NCT01543113 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
NCT00049010 ·Status: COMPLETED ·Phase: NA
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
NCT02251314 ·Status: COMPLETED